MIRA INFORM REPORT

 

 

 

Report Date :

26.09.2008

 

IDENTIFICATION DETAILS

 

Name :

HIPOLABOR FARMACEUTICA LTDA.

 

 

Registered Office :

Rodovia BR 262, S/N°, KM 12,3 - Bairro Borges 34735-000 - Sabará/MG

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2007

 

 

Date of Incorporation :

02.07.1984

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Manufacture of Pharmaceutical Products

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 1.000.000,00.

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 


name of the company

 

HIPOLABOR FARMACEUTICA LTDA.

 

 

ADDRESSES

 

MAIN ADDRESS:

RODOVIA BR 262, S/N°, KM 12,3 - BAIRRO BORGES

ZIP CODE/CITY:

34735-000 - SABARÁ/MG

 

 

PHONE:

31 3408-1800

FAX:

31 3408-1800

E-MAIL:

robertoloures@hipolabor.com.br

WEB SITE:

www.hipolabor.com.br

 

BRANCHES:

 

 

 

ADDRESS:

RODOVIA BR 262,4600 - AARÃO REIS

ZIP CODE/CITY:

31950-640 BELO HORIZONTE/MG

PHONE:

31 3408-1800

FAX:

31 3408-1802

CNPJ:

19.570.720/0003-82

STATE REGISTER:

062.425899-01-58

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICAL PRODUCTS.

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

02/07/1984

REGISTER DATE:

02/07/1984

BALANCE SHEET FILING DATE:

12/31

TAX CONTRIBUTOR NUMBER(CNPJ):

19.570.720/0001-10

STATE REGISTER:

567425.899.00-73

 

 

SHARE CAPITAL:

R$ 4.404.020,00

LAST REGISTER OF CAPITAL:

26/01/2004

 

BOARD OF DIRECTORS:

 

 

 

ILDEU DE OLIVEIRA N. DE MAGALHÃES

SUPERVISING DIRECTOR

 


 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTOR IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

ILDEU DE OLIVEIRA MAGALHÃES

97%

VIRGÍNIA ARANTES NEVES DE MAGALHÃES

1%

GUSTAVO NEVES DE MAGALHÃES

1%

ANDRÉ NEVES MAGALHÃES

1%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

NOT AVAILABLE.

 

 

 

COMPANY'S BACKGROUND

THE SUBJECT'S ACTIVITIES WERE STARTED ON JULY, 02 1984 BY THE COMPANY KANDA INDUSTRIA FARMACÊUTICA LTDA.

 

ON APRIL, 30 1999 THAT COMPANY WAS TAKEN OVER BY THE SUBJECT WHICH THEN TOOK OVER ALL THE ACTIVITIES WHICH WERE FORMERLY CARRIED OUT BY THE KANDA.

 

SINCE THAT TAKEOVER THEREFORE, ALL THE ACTIVITIES ARE CARRIED OUT BY THE SUBJECT COMPANY, OPERATING WITH THE REGISTERED NAME HIPOLABOR FARMACÊUTICA LTDA.

 

PARTNERS:

 

ILDEU DE OLVEIFRA MAGALHÃES: BRAZILIAN, MARRIED, INDUSTRIAL, RESIDENTIAL ADDRESS AT RUA DESEMBARGADOR FÁBIO MALDONADO Nº174, BELO HORIZONTE, MG, HOLDER OF DOCUMENTS RG M- 570.996 AND CPF 138.361.376/15.

 

VIRGINIA ARANTES NEVES DE MAGALHÃES IS BRAZILIAN, BUSINESS ADMINISTRATOR, RESIDENTIAL ADDRESS AT RUA DESEMBARGADOR FÁBIO MALDONADO Nº174, BELO HORIZONTE, MG, HOLDER OF DOCUMENTS RG M-995.424 AND CPF 315221496-00.

 

GUSTAVO NEVES DE MAGALHÃES: BRAZILIAN, SINGLE, RESIDENTIAL ADDRESS AT RUA DESEMBARGADOR FÁBIO MALDONADO Nº174, BELO HORIZONTE/MG, HOLDER OF DOCUMENTS, RG MG-10.742.772SSP/MG E CPF 053.214.066-42;

 

ANDRÉ NEVES MAGALHÃES: BRAZILIAN, SINGLE, EMPRESÁRIO, RESIDENTIAL ADDRESS AT RUA DESEMBARGADOR FÁBIO MALDONADO Nº174, BELO HORIZONTE/MG, HOLDER OF DOCUMENTS, RG MG-11.531.172SSP/MG E CPF 059.035.236-92.

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2007, 31/12/2006 AND 31/12/2005.

( FIGURES ARE IN REAIS ).

 

 

ASSETS

 

 

 

CURRENT:

31/12/2007

31/12/2006

31/12/2005

 

 

 

 

CASH AND BANKS

17.139.127,66

18.578.594,99

15.921.860,84

CLIENTS

20.454.395,88

19.142.583,73

21.513.653,38

INVENTORY

7.474.616,29

8.438.310,01

7.842.926,44

CHECKS

51.335,20

89.886,83

141.578,30

ADVANCE TO SUPPLIERS

2.120.749,46

243.459,67

87.321,41

ADVANCE TO EMPLOYEES

246.608,29

93.269,70

115.084,10

DEPOSITS & GUARANTEE

10.535,24

10.535,24

10.535,24

RECOVERABLE TAXES

2.956.639,25

1.505.784,04

891.466,35

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

50.454.007,27

48.102.424,21

46.524.426,06

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

JUDICIAL DEPOSITS

1.044.806,30

430.278,44

355.284,02

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

1.044.806,30

430.278,44

355.284,02

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

1.003.074,79

1.003.074,79

1.003.074,79

FIXED ASSETS

18.632.307,20

19.525.410,89

20.629.376,38

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

19.635.381,99

20.528.485,68

21.632.451,17

 

================

================

================

TOTAL ASSETS

71.134.195,56

69.061.188,33

68.512.161,25

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2007

31/12/2006

31/12/2005

 

 

 

 

SUPPLIERS

4.609.794,95

4.773.664,42

5.569.654,03

LABOR OBLIGATIONS

639.459,80

687.235,68

604.816,32

TRIBUTARY OBLIGATIONS

904.547,01

1.295.601,79

1.531.326,17

SOCIAL OBLIGATIONS

371.640,43

353.395,36

309.827,18

LOANS AND FINANCING

296.100,57

932.567,82

2.281.635,16

OTHER

441.445,14

182.650,73

264.564,75

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

7.262.987,90

8.225.115,80

10.561.823,61

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

11.731.415,26

13.378.121,83

12.079.994,88

INSTALLMENTS TAXES PAYABLE

25.781,93

295.564,55

601.211,63

INTERESTS ON OWN CAPITAL

3.539.285,02

1.973.444,12

 

TAXES AND CONTRIBUTIONS

4.159.508,41

4.615.805,23

5.067.822,32

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

19.455.990,62

20.262.935,73

17.749.028,83

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

4.404.020,00

4.404.020,00

4.404.020,00

REVALUATION RESERVES

8.945.431,42

9.830.989,96

10.708.434,92

CAPITAL RESERVES

800.000,00

800.000,00

800.000,00

PROFIT RESERVES

880.804,00

880.804,00

880.804,00

ACCRUED PROFIT (LOSS)

29.384.961,62

24.657.322,84

23.408.049,89

 

----------------

----------------

----------------

TOTAL NET EQUITY

44.415.217,04

40.573.136,80

40.201.308,81

 

================

================

================

TOTAL LIABILITIES

71.134.195,56

69.061.188,33

68.512.161,25

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2007, 31/12/2006 AND 31/12/2005.

( FIGURES ARE IN REAIS ).

 

31/12/2007

31/12/2006

31/12/2005

 

 

 

 

GROSS SALES

86.717.237,39

95.846.358,92

100.805.941,06

(-) TAXES ON SALES

10.528.104,63

17.477.279,60

18.533.604,79

 

----------------

----------------

----------------

NET SALES

76.189.132,76

78.369.079,32

82.272.336,27

(-) COST OF SOLD GOODS

52.566.792,85

53.140.814,78

49.638.300,47

 

----------------

----------------

----------------

GROSS PROFIT

23.622.339,91

25.228.264,54

32.634.035,80

OPERATING REVENUE (EXPENSE)

-15.813.829,85

-19.385.749,71

-15.615.213,17

FINANCIAL REVENUE(EXPENSE)

-2.797.670,59

-3.343.303,12

-3.481.237,64

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

5.010.839,47

2.499.211,71

13.537.584,99

NON-OPERATING RESULT

1.145.464,47

-688.961,94

-82.751,10

CONTRIBUTION/INCOME TAX

-2.154.223,70

-1.438.421,78

-1.934.424,05

PROFIT SHARING

-160.000,00

 

 

 

----------------

----------------

----------------

NET PROFIT (LOSS)

3.842.080,24

371.827,99

11.520.409,84

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RATIOS:

31/12/2007

31/12/2006

31/12/2005

 

QUICK RATIO

5,92

 

4,82

 

3,66

 

CURRENT RATIO

6,95

 

5,85

 

4,41

 

ACCOUNTS RECEIVABLE TURNOVER

3,72

TIMES

4,09

TIMES

3,82

TIMES

DAYS' SALES IN RECEIVABLES

96,65

DAYS

87,93

DAYS

94,14

DAYS

INVENTORY TURNOVER

7,03

TIMES

6,30

TIMES

6,33

TIMES

ACCOUNTS PAYABLE PERIOD

31,57

DAYS

32,34

DAYS

40,39

DAYS

RETURN ON ASSETS

1,07

TIMES

1,13

TIMES

1,20

TIMES

SALES TURNOVER ON NET EQUITY

1,72

TIMES

1,93

TIMES

2,05

TIMES

NET WORTH TIE-UP

,42

 

,48

 

,51

 

INDEBTEDNESS

,60

 

,70

 

,70

 

EQUITY RATIO

62,44

%

58,75

%

58,68

%

WORKING CAPITAL RATIO

594,67

%

484,82

%

340,50

%

GENERAL SOLVENCY

2,66

 

2,42

 

2,42

 

RETURN ON NET EQUITY

8,65

%

,92

%

28,66

%

RETURN ON SALES (PROFIT MARGIN)

5,04

%

,47

%

14,00

%

GROSS PROFIT MARGIN

31,00

%

32,19

%

39,67

%

OPERATIONAL RESULT

6,58

%

3,19

%

16,45

%

SALES TURNOVER ON LIABILITIES

10,49

TIMES

9,53

TIMES

7,79

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 1,82

 - OFFICIAL RATE ON 23/09/2008

US$ 1,00 = R$ 1,77

 - OFFICIAL RATE ON 31/12/2007

US$ 1,00 = R$ 2,13

 - OFFICIAL RATE ON 31/12/2006

US$ 1,00 = R$ 2,34

 - OFFICIAL RATE ON 31/12/2005

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A NORMAL FINANCIAL SITUATION. THE LEVEL OF INDEBTEDNESS IS LOW AND THE LIQUIDITY INCREASED. IT IS NOTED DOWNWARD SALES TREND BUT THE PROFITABILITY IMPROVED.

 

TOTAL OF SALES UNTIL AUGUST 2008 : R$ 69.133.400,00.

 

 

REAL ESTATE:

 

OWNED PREMISES ARE VALUED AT R$ 3.000.000,00

 

VEHICLES:

 

OWNED VEHICLES ARE VALUED AT R$ 25.000,00

 

MACHINES:

 

NOT AVAILABLE

 

 

INSURANCE

 

NOT DISCLOSED.

 

 

BANKING REFERENCES

 

BRANCH/PHONE:

CITY:

BANCO DO BRASIL S/A

ALTEROSA

CONTAGEM/MG

BANCO RURAL S/A

SANTO AGOSTINHO

BELO HORIZONTE/MG

BANCO NOSSA CAIXA S/A

AV BRASIL, 1497 - FUNCIONÁRIOS

BELO HORIZONTE/MG

 

 

 

 

 

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK"). DATE RESEARCHED SEPTEMBER 23, 2008.

 

 

 

 

 

 

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE OF PHARMACEUTICAL PRODUCTS.

 

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

GERMANY, INDIA, ENGLAND AND SWITZERLAND

 

EXPORTS TO:

DOES NOT EXPORT.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

PHONE:

BH FARMA COMERCIO E REPRESENTAÇÕES LTDA

BELO HORIZONTE/MG

31 3421-9400

POLAR FIX MATERIAL HOSPITALAR LTDA

MAUÁ/SP

11 451-2860

SECRETARIA MUNICIPAL DE SAÚDE

RIO DE JANEIRO/RJ

21 2503-2221

 

STAFF:

 

THE COMPANY HAS: 465 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1984. SO FAR IT HAS A CLEAR TRADE HISTORY AND NORMAL PAYMENT BEHAVIOR.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

 

 

 

 

 

 

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

PHONE:

ALLPLAS IND. E COMÉRCIO PLÁSTICOS LTDA

 

11 4613-1000

CIV CIA IND. DE VIDROS

 

11 2172-7433

GALENA QUÍMICA E FARMACÊUTICA LTDA

 

0800-144150

M. CASSAB COMÉRCIO E IND. LTDA

 

31 3411-2817

OXITENO NORDESTE S/A INDUSTRIA E COMERCIO

 

11 3177-6974

SAINT GOBAIN VIDROS S/A

 

11 3874-7551

SCHOTT DO BRASIL LTDA

 

11 4591-0223

SHEELMAR EMBALAGEM MODERNA LTDA

 

31 3287-7566

 


 

PAYMENT HISTORY:

 

18 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 125.778,00

 

AMOUNT OF INVOICES PAID: 80

TOTAL OF PROMPT PAYMENTS: 97,8%

TOTAL OF DELAYED PAYMENTS: 2,2%

 

HIGHEST INVOICE: R$ 46.386,00

HIGHEST CREDIT: R$ 46.386,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 60 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

1

2

R$ 1.255,00

DUE WITHIN 60 DAYS

1

1

R$ 2.930,00

ALL

2

3

R$ 4.185,00

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT PERFORMANCE.

 

BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

THE COMPANY HAS PAYMENT CAPACITY AND IS CONSIDERED CREDITWORTHY FOR A CREDIT LIMIT OF US$ 1.000.000,00.

 

 

 

 

 


 

HIPOLABOR FARMACEUTICA LTDA.

 

 

BALANCE SHEET ANALYSIS

FIGURES ARE IN REAIS

 

 

31-12-07

 

ASSETS

 

%

Current Assets

 $            50,454,007

70.93

Fixed Assets

 $            19,635,382

27.60

TOTAL ASSETS

 $            71,134,196

100.00

LIABILITIES

 

 

Current Liabilities

 $              7,262,988

10.21

Long-Term Liabilities

 $            19,455,991

27.35

TOTAL LIABILITIES

 $            26,718,979

37.56

Deferred Income

 $                            -  

0.00

Net Equity

 $            44,415,217

62.44

TOTAL LIABILITIES + NET EQUITY

 $            71,134,196

100.00

PROFIT AND LOSS ACCOUNTS

 

 

Net Sales

 $            76,189,133

100.00

Costs

 $            52,566,793

69.00

Gross Profit

 $            23,622,340

31.00

Operating expenses

 $          (15,813,830)

-20.76

operational Result

 $              5,010,839

6.58

Net Profit (loss)

 $              3,842,080

5.04

COMPLEMENTARY DATA

 

 

Inventory

 $              7,474,616

 

Accounts receivable

 $            20,454,396

 

Accounts Payable

 $              4,609,795

 

Property, plant and equipment

 $            18,632,307

 

Purchases

 $            19,635,382

 

Financial Expenses

 $             (2,797,671)

 

Foreign Currency Assets

 

 

Foreign Currency Liabilities

 

 

Working Capital

 $            43,191,019

 

RATIOS:

 

 

QUICK RATIO

                           5.92

 

CURRENT RATIO

                           6.95

 

ACCOUNTS RECEIVABLE TURNOVER

                           3.72

times

DAYS' SALES IN RECEIVABLES

                         96.65

days

INVENTORY TURNOVER

                           7.03

times

ACCOUNTS PAYABLE PERIOD

                         31.57

days

RETURN ON ASSETS

                           1.07

times

SALES TURNOVER ON NET EQUIY

                           1.72

times

NET WORTH TIE-UP

                           0.42

 

ENDEBTEDNESS

                           0.60

 

EQUITY RATIO

                         62.44

%

WORKING CAPITAL RATIO

                       594.67

%

GENERAL SOLVENCY

                           2.66

 

RETURN ON NET EQUITY

                           8.65

%

RETURN ON SALES (PROFIT MARGIN)

                           5.04

%

GROSS PROFIT MARGIN

                         31.00

%

OPERATIONAL RESULT

                           6.58

%

SALES TURNOVER ON LIABILITIES

                         10.49

times

FOREIGN CURRENCY ON ASSETS

                               -  

%

FOREIGN CURRENCY ON LIABILITIES

                               -  

%

 

HIPOLABOR FARMACEUTICA LTDA.

 

 

 

 

BALANCE SHEET ANALYSIS

 

 

 

 

 

31-12-06

 

31-12-05

 

ASSETS

 

%

 

%

Current Assets

 $            48,102,424

69.65

 $        46,524,426

67.91

Fixed Assets

 $            20,528,486

29.73

 $        21,632,451

31.57

TOTAL ASSETS

 $            69,061,188

100.00

 $        68,512,161

100.00

LIABILITIES

 

 

 

 

Current Liabilities

 $              8,225,116

11.91

 $        10,561,824

15.42

Long-Term Liabilities

 $            20,262,936

29.34

 $        17,749,029

25.91

TOTAL LIABILITIES

 $            28,488,052

41.25

 $        28,310,852

41.32

Deferred Income

 $                            -  

0.00

 $                        -  

0.00

Net Equity

 $            40,573,137

58.75

 $        40,201,309

58.68

TOTAL LIABILITIES + NET EQUITY

 $            69,061,188

100.00

 $        68,512,161

100.00

PROFIT AND LOSS ACCOUNTS

 

 

 

 

Net Sales

 $            78,369,079

100.00

 $        82,272,336

100.00

Costs

 $            53,140,815

67.81

 $        49,638,300

60.33

Gross Profit

 $            25,228,265

32.19

 $        32,634,036

39.67

Operating expenses

 $          (19,385,750)

-24.74

 $      (15,615,213)

-18.98

operational Result

 $              2,499,212

3.19

 $        13,537,585

16.45

Net Profit (loss)

 $                 371,828

0.47

 $        11,520,410

14.00

COMPLEMENTARY DATA

 

 

 

 

Inventory

 $              8,438,310

 

 $          7,842,926

 

Accounts receivable

 $            19,142,584

 

 $        21,513,653

 

Accounts Payable

 $              4,773,664

 

 $          5,569,654

 

Property, plant and equipment

 $            19,525,411

 

 $        20,629,376

 

Purchases

 $            20,528,486

 

 $        21,632,451

 

Financial Expenses

 $             (3,343,303)

 

 $         (3,481,238)

 

Foreign Currency Assets

 

 

 

 

Foreign Currency Liabilities

 

 

 

 

Working Capital

 $            39,877,308

 

 $        35,962,602

 

RATIOS:

 

 

 

 

QUICK RATIO

                           4.82

 

                       3.66

 

CURRENT RATIO

                           5.85

 

                       4.40

 

ACCOUNTS RECEIVABLE TURNOVER

                           4.09

times

                       3.82

times

DAYS' SALES IN RECEIVABLES

                         87.93

days

                     94.14

days

INVENTORY TURNOVER

                           6.30

times

                       6.33

times

ACCOUNTS PAYABLE PERIOD

                         32.34

days

                     40.39

days

RETURN ON ASSETS

                           1.13

times

                       1.20

times

SALES TURNOVER ON NET EQUIY

                           1.93

times

                       2.05

times

NET WORTH TIE-UP

                           0.48

 

                       0.51

 

ENDEBTEDNESS

                           0.70

 

                       0.70

 

EQUITY RATIO

                         58.75

%

                     58.68

%

WORKING CAPITAL RATIO

                       484.82

%

                   340.50

%

GENERAL SOLVENCY

                           2.42

 

                       2.42

 

RETURN ON NET EQUITY

                           0.92

%

                     28.66

%

RETURN ON SALES (PROFIT MARGIN)

                           0.47

%

                     14.00

%

GROSS PROFIT MARGIN

                         32.19

%

                     39.67

%

OPERATIONAL RESULT

                           3.19

%

                     16.45

%

SALES TURNOVER ON LIABILITIES

                           9.53

times

                       7.79

times

FOREIGN CURRENCY ON ASSETS

                               -  

%

                           -  

%

FOREIGN CURRENCY ON LIABILITIES

                               -  

%

                           -  

%

 

 

 

                                    

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.46.43

UK Pound

1

Rs.85.38

Euro

1

Rs.67.95

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions